Recent RNA-Related Papers of Note

Nov 21, 2003

Premium

File Attachments

RNAiLab112103.gif

Filed under

Gene Silencing/Gene Editing

RNAi

Breaking News

Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test
Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing
Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing
Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel
Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets
LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.